4//SEC Filing
Cheruvu Pavan 4
Accession 0001209191-18-010478
CIK 0001636050other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:43 PM ET
Size
5.9 KB
Accession
0001209191-18-010478
Insider Transaction Report
Form 4
Cheruvu Pavan
Chief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-02-13+1,940,185→ 1,940,185 totalExercise: $1.81Exp: 2028-02-12→ Common Shares (1,940,185 underlying)
Footnotes (1)
- [F1]25% of the common shares underlying the option will vest on February 11, 2019; the remainder vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
Documents
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001731741
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:43 PM ET
- Size
- 5.9 KB